Systemic vasculitis: How little we know about their societal and economic burden

Clinical and Experimental Rheumatology

Volumn 30, Issue 4 SUPPL.73, 2012, Pages

  Trieste, L ^a   Palla, I ^a   Baldini, C ^b   Talarico, R ^b   D'Angiolella, L ^c   Mosca, M ^b   Turchetti, G ^a  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Fondazione Charta   (Italy)

Author keywords

Direct costs; Indirect costs; Systemic vasculitis

Indexed keywords

ARTICLE; BEHCET DISEASE; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIAGNOSIS RELATED GROUP; DISEASE SEVERITY; EMPLOYMENT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HOSPITAL COST; HUMAN; INVESTMENT; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIOECONOMICS; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

COST OF ILLNESS; COSTS AND COST ANALYSIS; HEALTH CARE COSTS; HUMANS; SYSTEMIC VASCULITIS;

EID: 84870262135     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. CARPENTER DM, MEADOR AE, ESTAD EA, HOGAN SL, DE VELLIS RF: The impact of vasculitis on patients' social participation and friendships. Clin Exp Rheumatol 2012;30:S15-S21.
2. TALARICO R, BALDINI C, DELLA ROSSA A et al.: Large-and small-vessel vasculitis: a critical digest of the 2010-2011 literature. Clin Exp Rheumatol 2012;30(Suppl 70):S130-8.
3. MOSCA M, BOUMPAS D, BRUCE IN et al.: Treat-to-target in systemic lupus erythematosus: where are we today? Clin Exp Rheumarol 2012;30(Suppl. 73):S112-S115.
4. CENTRE FOR REVIEWS AND DISSEMINATION: CRD's Guidance for Undertaking Reviews in Health Care, 2008, University of York.
5. Cochrane Handbook for Systematic Reviews of interventions, Edited by HIGGINS J P T and GREEN S, 2008, Wiley-Blackwell.
6. KRULICHOVA I, GAMBA S, RICCI E, GARATTINI L: Direct medical costs of monitoring and treating patients with Takayasu arteritis in Italy. Eu J Health Econ 2004;49:330-4.
7. SUT N, SEYAHI E, YURDAKUL S, SENOCAK M, YAZICI H: A cost analysis of Behçet's syndrome in Turkey. Rheumatology 2007;46:678-82.
8. REINHOLD-KELLER E, HERLYN K, WAGNER-BASTMEYER R et al.: Effect of Wegener's Granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis. Arthritis Rheum (Arthritis Care Res) 2002;47:320-5.
9. ABULARRAGE CJ, SLIDELL MB, SIDAWY AN, KREISHMAN P, AMDUR RL, ARORA S: Quality of life of patients with Takayasu's arteritis. J Vasc Surg 2008;131-7.
10. ERTAM I, KITAPCIOGLU G, AKSU K et al.: Quality of life and its relation with disease severity in Behçet's disease. Clin Exp Rheumatol 2009;27:S18-S22.
11. TALARICO R, D'ASCANIO A, FIGUS M et al.: Behçet's disease: features of neurological involvement in a dedicated centre in Italy. Clin Exp Rheumatol 2012 Sep. 25 [Epub].
12. FURNERI G, MANTOVANI LG, BELISARI A et al.: Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis. Clin Exp Rheumatol 2012;30(Suppl.73):S72-S84.
13. TURCHETTI G, YAZDANY J, PALLA I, YELIN E, MOSCA M: Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider. Clin Exp Rheumatol 2012;30(Suppl. 73):S117-S123.
14. PALLA I, TRIESTE L, TANI C et al.: A systematic literature review of the economic impact of ankylosing spondylitis. Clin Exp Rheumatol 2012;30(Suppl. 73):S136-S141.
15. TRIESTE L, PALLA I, FUSCO F et al.: The economic impact of gout: systematic literature review. Clin Exp Rheumatol 2012;30(Suppl. 73):S145-S148.
16. CORTESI PA, SCALONE L, D'ANGIOLELLA L et al.: Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis. Clin Exp Rheumatol 2012;30(Suppl. 73):S126-S131.
17. TURCHETTI, G, SPADONI E, GEISLER E: Health technology assessment. Evaluation of biomedical innovative technologies. IEEE Engineering in Medicine and Biology Magazine 2010;29:70-6.
18. TURCHETTI G, SCALONE L, DELLA CAS A, AL-BERIGHI O et al.: The rationale of pharmacoeconomic analysis in rheumatologic indications. Clin Exp Rheumatol 2012;30(Suppl. 73):S64-S71.